Secondary Malignant Neoplasms After Childhood Cancer

REFERENCES

• Bhatia S, Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer. 2002;2:124–132.
   PubMed Web of Science ®Google Scholar
• Neglia JP, Friedman DL, Yasui Y, Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93:618–629.
   PubMed Web of Science ®Google Scholar
• Robison LL, Mertens A. Second tumors after treatment of childhood malignancies. Hematol Oncol Clin North Am. 1993;7:401–415.
   PubMed Web of Science ®Google Scholar
• Naugut A, Meadows AT, Robinson E. Multiple Primary Cancers. Philadelphia: Lippincott Williams and Wilkins; 1999:3–10.
   Google Scholar
• Olsen JH, Garwicz S, Hertz H, Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. BMJ 1993;307:1030–1036.
   PubMedGoogle Scholar
• Neglia JP. Childhood cancer survivors. Past, present, and future. Cancer. 1994;73:2883–2885.
   PubMedGoogle Scholar
• Bhatia S, Yasui Y, Robison LL, High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the late effects study group. J Clin Oncol. 2003;21:4386–4394.
   PubMed Web of Science ®Google Scholar
• Bhatia S, Robison LL, Oberlin O, Breast cancer and other second neoplasms after childhood Hodgkin disease. N Engl J Med. 1996;334:745–751.
   PubMed Web of Science ®Google Scholar
• Tucker MA, Meadows AT, Boice JD, Cancer risk following treatment of childhood cancer. In: Boice JD, Fraumeni JF, eds. Radiation Carcinogenesis: Epidemiology and Biological Significance. New York: Raven Press; 1984:211–224.
   Google Scholar
• Davies SM. Therapy-related leukemia associated with alkylating agents. Med Pediatr Oncol. 2001;36:536–540.
   PubMedGoogle Scholar
• Felix CA. Leukemias related to treatment with DNA topoisomerase II inhibitors. Med Pediatr Oncol. 2001;36:525–535.
   PubMedGoogle Scholar
• Loning L, Zimmermann M, Reiter A, Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood. 2000;95:2770–2775.
   PubMed Web of Science ®Google Scholar
• Rubino C, Shamsaldin A, Le MG, Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment. Breast Cancer Res Treat. 2005;89:277–288.
   PubMed Web of Science ®Google Scholar
• Kuttesch JF Jr, Wexler LH, Marcus RB, Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol. 1996;14:2815–2825.
   Google Scholar
• Hall EJ. Henry S. Kaplan Distinguished Scientist Award 2003. The crooked shall be made straight; dose-response relationship for carcinogenesis. Int J Radiat Biol. 2004;80:327–337.
   PubMed Web of Science ®Google Scholar
• Gold DG, Neglia JP, Dusenbery KE. Second neoplasms after megavoltage radiation for pediatric tumors. Cancer. 2003;97:2588–2596.
   PubMed Web of Science ®Google Scholar
• Boice JD Jr. Radiation and breast carcinogenesis. Med Pediatr Oncol. 2001;36:508–513.
   PubMedGoogle Scholar
• Shore RE. Radiation-induced skin cancer in humans. Med Pediatr Oncol. 2001;36:549–554.
   PubMedGoogle Scholar
• Inskip PD. Thyroid cancer after radiotherapy for childhood cancer. Med Pediatr Oncol. 2001;36:568–573.
   PubMedGoogle Scholar
• Kaste SC, Hudson MM, Jones DJ, Breast masses in women treated for childhood cancer: incidence and screening guidelines. Cancer. 1998;82:784–792.
   PubMedGoogle Scholar
• Ng AK, Bernardo MV, Weller E, Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002;100:1989–1996.
   PubMed Web of Science ®Google Scholar
• Rabes HM. Gene rearrangements in radiation-induced thyroid carcinogenesis. Med Pediatr Oncol. 2001;36:574–582.
   PubMedGoogle Scholar
• Ferry C, Gemayel G, Rocha V, Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transpl. 2007;40:219–224.
   PubMed Web of Science ®Google Scholar
• Schneider RA, Schultze J, Jensen JM, Long-term outcome after static intensity-modulated total body radiotherapy using compensators stratified by pediatric and adult cohorts. Int J Radiat Oncol Biol Phys. 2008;70:194–202.
   PubMedGoogle Scholar
• Heymann S, Delaloge S, Rahal A, Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat Oncol. 2010;5:104.
   PubMed Web of Science ®Google Scholar
• Korf BR. Malignancy in neurofibromatosis type 1. Oncologist. 2000;5:477–485.
   PubMedGoogle Scholar
• Sharif S, Ferner R, Birch JM, Second primary tumors in neurofibromatosis type 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol. 2006;24:2570–2575.
   PubMed Web of Science ®Google Scholar
• Taylor AMR, Metcalfe JA, Thick J, Mak Y-F. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996;87:423–438.
   PubMed Web of Science ®Google Scholar
• Perentesis JP. Genetic predisposition and treatment-related leukemia. Med Pediatr Oncol. 2001;36:541–548.
   PubMedGoogle Scholar
• Hottinger AF, Khakoo Y. Neurooncology of familial cancer syndromes. J Child Neurol. 2009;24:1526–1535.
   PubMed Web of Science ®Google Scholar
• Vazquez E, Castellote A, Piqueras J, Second malignancies in pediatric patients: imaging findings and differential diagnosis. Radiographics. 2003;23:1155–1172.
   PubMedGoogle Scholar
• Atahan IL, Yildiz F, Ozyar E, Basal cell carcinomas developing in a case of medulloblastoma associated with Gorlin's syndrome. Pediatr Hematol Oncol. 1998;15:187–191.
   PubMed Web of Science ®Google Scholar
• Çağlar K, Varan A, Akyüz C, Second neoplasms in pediatric patients treated for cancer: a center's 30-year experience. J Pediatr Hematol Oncol. 2006;28:374–378.
   PubMed Web of Science ®Google Scholar
• Varan A, Akyüz C, Büyükpamukçu M. A rare presentation of trilateral retinoblastoma. Tumori. 1998;84:515–516.
   PubMedGoogle Scholar
• Yazici N, Sarialioğlu F, Alkan Ö, Kayaselçuk F, Erol I. l-2-Hyroxyglutaric aciduria and brain tumors: a case report and review of the literature. J Pediatr Hematol Oncol. 2009;31:865–869.
   PubMedGoogle Scholar
• Rothman K, Keller A. The effect of joint exposure to alcohol and tobacco on risk of cancer of the mouth and pharynx. J Chronic Dis. 1972;25:711–716.
   PubMedGoogle Scholar
• Flanders WD, Rothman KJ. Interaction of alcohol and tobacco in laryngeal cancer. Am J Epidemiol. 1982;115:371–379.
   PubMed Web of Science ®Google Scholar
• LaVecchia C, Negri E. The role of alcohol in esophageal cancer in nonsmokers, and of tobacco in nondrinkers. Int J Cancer. 1989;43:784–785.
   PubMed Web of Science ®Google Scholar
• Travis LB. Therapy-associated solid tumors. Acta Oncol. 2002;41:323–333.
   PubMed Web of Science ®Google Scholar
• Gow KW, Lensing S, Hill DA, Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: an institutional experience and review of the literature. J Pediatr Surg. 2003;38:1574–1580.
   PubMed Web of Science ®Google Scholar
• Rosso P, Terracini B, Fears TR, Second malignant tumors after elective end of therapy for a first cancer in childhood: a multicenter study in Italy. Int J Cancer. 1994;59:451–456.
   PubMedGoogle Scholar
• Garaventa A, Haupt R, Panarello C, Early occurrence of a secondary thyroid carcinoma in a child treated for Hodgkin disease. Med Pediatr Oncol. 2001;36:396–397.
   PubMedGoogle Scholar
• Ragusa R, Russo S, Villari L, Schiliro G. Hodgkin's disease as a second malignant neoplasm in childhood: report of a case and review of the literature. Pediatr Hematol Oncol. 2001;18:407–414.
   PubMed Web of Science ®Google Scholar
• Humpl T, Fritsche M, Bartels U, Gutjahr P. Survivors of childhood cancer for more than twenty years. Acta Oncol. 2001;40:44–49.
   PubMed Web of Science ®Google Scholar
• Leung W, Sandlund JT, Hudson MM, Second malignancy after treatment of childhood non-Hodgkin lymphoma. Cancer. 2001;92:1959–1966.
   PubMed Web of Science ®Google Scholar
• Kowalczyk JR, Nurzynska J, Armata J, International note: second malignant neoplasms in children: a multicenter study of the Polish Pediatric Leukemia/Lymphoma Group. Med Pediatr Oncol. 2002;38:421–423.
   PubMedGoogle Scholar
• Rubino C, de Vathaire F, Dottorini ME, Second primary malignancies in thyroid cancer patients. Br J Cancer. 2003;89:1638–1644.
   PubMed Web of Science ®Google Scholar
• Pettorini BL, Park YS, Caldarelli M, Radiation-induced brain tumors after central nervous system irradiation in childhood: a review. Child Nerv Syst. 2008;24:793–805.
   PubMed Web of Science ®Google Scholar
• Büyükpamukçu M, Varan A, Yazıcı N, Second malignant neoplasms following the treatment of brain tumors in children. J Child Neurol. 2006;21:434–436.
   Google Scholar
• Hildebrand J, Malarme M, Flament-Durand J, Stryckmans P. Acute nonlymphoblastic leukemia in a patient treated for brain tumor. Arch Neurol. 1982;39:664–665.
   PubMedGoogle Scholar
• Casteels K, Renard M, Van Gool S, Uyttebroeck A. Secondary acute lymphoblastic leukemia in a child three years after treatment for medulloblastoma. Med Pediatr Oncol. 2001;36:390–391.
   PubMedGoogle Scholar
• Wenzel CT, Halperin EC, Fisher SR. Second malignant neoplasms of the head and neck in survivors of retinoblastoma. Ear Nose Throat J. 2001;80: 106, 109–112.
   Google Scholar
• de Vathaire F, Hawkins M, Campbell S, Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment. Br J Cancer. 1999;79:1884–1893.
   PubMed Web of Science ®Google Scholar
• Rich DC, Corpron CA, Smith MB, Second malignant neoplasms in children after treatment of soft tissue sarcoma. J Pediatr Surg. 1997;32:369–372.
   PubMedGoogle Scholar
• Kebudi R, Ayan İ, Görgün Ö, Second malignant tumors in childhood cancer survivors. Pediatr Blood Cancer. 2007;49:553.
   Google Scholar